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Abstract
Background: Increased levels of interferon (IFN)-inducible IFI16 protein (encoded by the IFI16 gene located at 1q22) in
human normal prostate epithelial cells and diploid fibroblasts (HDFs) are associated with the onset of cellular senescence.
However, the molecular mechanisms by which the IFI16 protein contributes to cellular senescence-associated cell growth
arrest remain to be elucidated. Here, we report that increased levels of IFI16 protein in normal HDFs and in HeLa cells
negatively regulate the expression of human telomerase reverse transcriptase (hTERT) gene.
Methodology/Principal Findings: We optimized conditions for real-time PCR, immunoblotting, and telomere repeat
amplification protocol (TRAP) assays to detect relatively low levels of hTERT mRNA, protein, and telomerase activity that are
found in HDFs. Using the optimized conditions, we report that treatment of HDFs with inhibitors of cell cycle progression,
such as aphidicolin or CGK1026, which resulted in reduced steady-state levels of IFI16 mRNA and protein, was associated
with increases in hTERT mRNA and protein levels and telomerase activity. In contrast, knockdown of IFI16 expression in cells
increased the expression of c-Myc, a positive regulator of hTERT expression. Additionally, over-expression of IFI16 protein in
cells inhibited the c-Myc-mediated stimulation of the activity of hTERT-luc-reporter and reduced the steady-state levels of
c-Myc and hTERT.
Conclusions/Significance: These data demonstrated that increased levels of IFI16 protein in HDFs down-regulate the
expression of hTERT gene. Our observations will serve basis to understand how increased cellular levels of the IFI16 protein
may contribute to certain aging-dependent diseases.
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Introduction
The interferon (IFN) family of cytokines exhibits multiple
biological activities both in vitro and in vivo [1–4]. The family
includes type-I (IFN-a and IFN-b) and type-II (IFN-c) IFNs
among others [1–3]. The biological activities of IFNs include the
cell growth-inhibitory activities [1–5]. Studies have suggested that
expression of a set of IFN-inducible genes, which encode proteins
that mediate the biological activities of IFNs [1,6], is up-regulated
during the onset of cellular senescence in a variety of human cells
[7–11]. Moreover, the loss of expression of IFN-inducible genes is
correlated with immortalization of cells and the development of
certain human cancers [7,11]. These observations have suggested
a role for IFN-inducible proteins in the regulation of cellular
senescence.
Our studies [12–14] have revealed that increased expression of
IFN-inducible IFI16 protein in human normal prostate epithelial
cells and HDFs contributes to cellular senescence. These studies
demonstrated that knockdown of IFI16 expression in HDFs
prolonged the proliferation potential [12], whereas overexpression
of IFI16 protein in PC-3 human prostate cancer cell line resulted in
senescence-like phenotype and reduced telomere length [13]. The
IFI16 protein is a member of structurally and functionally-related
family of proteins (the p200-proteins) [14]. The family includes the
murine (for example, p202a p202b, p203, and p204 etc.) and
human (for example, IFI16, MNDA, IFIX, and AIM2) proteins.
Increased expression of some of the p200-family of proteins inhibits
cell cycle progression by inhibiting the transcriptional activities of a
variety of growth-promoting transcription factors [15–17]. For
example, increased levels of the p202 protein (encoded by the
Ifi202a and Ifi202b genes) inhibit c-Myc-mediated transcription
[18]. Additionally, the p202 protein binds to the pRb pocket and
E2Fs (E2F1 and E2F4) and inhibits the E2F-stimulated transcrip-
tion of growth-promoting genes [19–21]. Similarly, the IFI16
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protein in prostate cancer cells inhibit the E2F1-mediated
transcription [13,14]. Additionally, overexpression of IFI16 protein
in human osteosarcoma cell line Saos-2 down-regulated the
expression of c-MYC and RAS genes [22]. Moreover, the IFI16
protein can bind to the promoter of the c-MYC gene in chromatin
immunoprecipitation assays [23]. Although, these observations
suggest that increased levels of IFI16 protein negative regulate the
expression of c-MYC in certain tumor cell lines, it remains unknown
how increased levels of the IFI16 protein in human normal cells
contribute to cellular senescence-associated cell growth arrest.
The telomere length is believed to be an important determinant
of cellular longevity and immortal cells often employ telomerase, a
ribonucleoprotein that elongates telomeres, to maintain telomere
length [24–26]. Indeed, increased expression of the catalytic
subunit of human telomerase reverse transcriptase (hTERT)
results in immortalization of certain human primary fibroblasts
and epithelial cells [24,25].
Most somatic cells are reported to express low levels of hTERT
protein [27–30] and disruption of the activity in normal cells slows
cell proliferation, restricts cell lifespan, and alters the maintenance
of the 39-single stranded telomeric overhang without changing the
rate of overall telomere shortening [25,26]. However, most tumor
cells possess relatively high telomerase activity [28,29]. This
differential display of telomerase activity is largely attributed to the
ability of tumor cells to up-regulate the expression of hTERT gene
[24].
Several cell signaling pathways regulate the activity of
transcription factors and co-regulators that regulate the expression
of hTERT gene [31,32]. The pathways that negatively regulate the
expression of hTERT include the IFN-signaling pathway [33–37].
It is known that IFN-treatment of certain cells down-regulates
hTERT expression and inhibits telomerase activity [33,35,37].
Additionally, the pRb/E2F pathway negatively regulates hTERT
expression [29,38]. It has been shown that the E2F-pocket protein-
histone deacetylase transcriptional repressor complex serves as a
key mechanistic basis for the repression of the hTERT gene in
normal human cells during the G1 phase of cell cycle [29].
Activation of cell signaling pathways by growth factors that results
in up-regulation of c-Myc expression positively regulate the
expression of hTERT gene [39–41].
The c-Myc oncoprotein is a transcription factor with basic,
helix-loop-helix, and leucine zipper domains (bHLHLZ) [42].
High-affinity sequence-specific DNA-binding of c-Myc requires
the heterodimeric partner Max [42]. A number of genes have been
implicated as the transcriptional targets of c-Myc, including the
hTERT gene [39–41]. Expression of c-Myc is down-regulated by in
vitro treatment of certain human cells and cell lines with IFNs
[43,44].
Our previous observations that increased levels of IFI16 protein
in human normal prostate epithelial cells [13] and fibroblasts [12]
are associated with cellular senescence-associated cell growth
arrest and immortalization of HDFs with hTERT results in down-
regulation of IFI16 expression prompted us to test whether IFI16
protein could regulate the expression of hTERT. Our observations
revealed that increased levels of IFI16 protein down-regulate the
expression of hTERT, in part, through inhibiting the c-Myc-
mediated transcription of the hTERT gene.
Materials and Methods
Cell Lines, Culture Conditions, and Treatments
HeLa cells were generously provided by Dr. Olivia Perriera-
Smith (University of Texas Health Science Center at San Antonio,
TX). Normal human fetal lung fibroblasts (AG06814N, WI-38) at
population doubling 15 (passage 12) were obtained from the
National Institute of Aging Cell Culture Repository (Coriell
Medical for Medical Research, Camden, NJ). HeLa cells and WI-
38 cell cultures were maintained in DMEM culture media with
high glucose, which was supplemented with 10% fetal bovine
serum and antibiotics (Invitrogen). Sub-confluent cultures of cells,
when indicated, were treated with either aphidicolin (5 mg/ml,
Calbiochem, San Diego, CA) or CGK1026 (10 mM) for the
indicated duration.
Plasmids and Expression Vectors
The plasmid pCMV-IFI16 has been described previously [13].
The plasmid (pCMV-c-Myc) encoding the human c-Myc protein
was originally provided by Dr. Robert Eisenman (Fred Hutch-
inson Cancer Research Center, Seattle, WA). The pMyc-TA-luc
reporter plasmid was purchased from BD Biosciences Clontech
(Palo Alto, CA) as a part of the BD Bioscience Pathway Profiling
System. The reporter contains six tandem copies of the E-box (c-
Myc DNA-binding sequence) consensus sequence, a minimal TA
promoter (the TATA box from the herpes simplex virus thymidine
kinase promoter), and the downstream to the minimal promoter
the firefly luciferase reporter gene. The hTERT-luc-reporter
plasmid containing the 59-regulatory region (from 21125 bp to
243 bp) of the human hTERT gene has been described previously
[45].
Overexpression or Knockdown of IFI16 Expression
Sub-confluent cultures of HeLa cells were either infected with
retroviral vector (LZRS-IFI16 or LZRS-IFI16AS) that allowed
expression of mRNA encoding the IFI16 protein and an antisense
to IFI16 mRNA, respectively. As a control, we infected cells with a
retroviral LZRS vector with only a linker sequence. To over-
express IFI16 protein in WI-38 cells, cells were nucleofected with
pCMV-IFI16 plasmid. As a negative control, cells were nucleo-
fected with an empty pCMV vector. To knockdown expression of
IFI16 in WI-38 cells, we used a pool of IFI16 siRNAs (purchased
from Dharmacon, Denver, CO) or a nonspecific control siRNA
(cat # D-001206-02-05) as recommended by the manufacturer
using Lipofectamine (Invitrogen) transfection agent. 60 h post-
transfections, cells were processed for immunoblotting.
Nucleofections
WI-38 cells were nucleofected with 2 mg of pCMV-IFI16
plasmid or pCMV highly purified (endotoxin-free) plasmid. The
Nucleofector-II device (Amaxa Biosystems, Germany) was used
(Nucleofection kit R and program V-001) as suggested by the
supplier. After nucleofections, cells were harvested at the indicated
times to isolate total RNA or to prepare total cell extracts.
Telomere Repeat Amplification Protocol Assays
To detect relatively low levels of the activity of telomerase in
human diploid fibroblasts, we optimized the assay conditions using
nuclear extracts prepared from decreasing numbers (2000, 1000,
500, 250, and 125) of HeLa cells that are known to express the
detectable levels of telomerase [46]. The telomerase activity was
detected using a TRAPeze Telomerase activity detection kit
(Chemicon International, Temecula, CA) as suggested by the
supplier.
Immunoblotting and Antibodies
To detect low basal levels of hTERT protein in human normal
WI-38 and BJ fibroblasts, we used nuclear extracts and our
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weight proteins [47]. In brief, after fractionation of cells into the
cytoplasmic and nuclear fractions, the nuclear fraction was
incubated with RIPA buffer and the lysates were subjected to
SDS-PAGE electrophoresis using pre-casted gels from Nupage
Bis-Tris (4–12%) gel systems (Invitrogen). Proteins were trans-
ferred to Immobilon-P (Millipore, Billerica, MA) membranes and
immunoblotting was performed as described previously [47].
Antibodies specific for IFI16 (sc-8023) and c-Myc (sc-40) were
purchased from Santa Cruz Biotech (Santa Cruz, CA). To detect
human hTERT protein, we used either a mouse monoclonal
antibody (NB100–317; from Novus Biologicals, Littleton, CO) or a
rabbit polyclonal antibody (sc-7212; from Santa Cruz Biotech,
CA). Antibody (cat # 4967) to b-actin was purchased from Cell
Signaling Technology (Danvers, MA). Horseradish peroxidase
(HRP) conjugated secondary anti-mouse (NXA-931) and anti-
rabbit (NA-934) antibodies were from Amersham Biosciences.
Reverse Transcriptase Reaction and Real-Time PCR
Total RNA was isolated from WI-38 fibroblasts with Trizol
reagent (Invitrogen, Carlsbad, CA, USA). cDNA synthesis was
done using primers with SuperScript First-strand Synthesis System
for RT-PCR (Invitrogen, Carlsbad, CA, USA). Quantitative real-
time TaqMan PCR technology (Applied Biosystems, Foster City,
CA, USA) was used. The PCR cycling program consisted of
denaturing at 95uC for 10 min and 40 cycles at 95uC for 15
seconds, and annealing and elongation at 60uC for 1 min. The
TaqMan assays for IFI16 (assay Id #Hs00194216_m1), hTERT
(assay Id# Hs00972646_m1), and for the endogenous control b-
actin (assay Id# Hs99999903_ml) were purchased from Applied
Biosystems (Foster City, CA) and used as suggested by the supplier.
Reporter Assays
All transient transfection assays were performed using FuGene6
transfection reagent (Roche, Indianapolis, IN) according to the
manufacturer’s instructions. In brief, sub-confluent cells were co-
transfected with desired reporter plasmid (c-Myc-luc or hTERT-
luc; 1.8 mg) along with pRL-TK plasmid (0.2 mg) as an internal
control. 48 h after transfections of cells, firefly luciferase and
Renilla luciferase activities were assayed using dual-luciferase
reporter assay kit (Promega, Madison, WI). Relative luciferase
activity was expressed as the ratio of the firefly luciferase and
Renilla luciferase activities. Student’s t-test for paired samples was
used to determine statistical significance of the reporter activity
data. Differences were considered statistically significant at
P#0.05.
Results
Expression of IFI16 Is Inversely Correlated with the hTERT
Expression
Our earlier observations [12] that immortalization of human
diploid fibroblasts with SV40 large T antigen or hTERT reduced
steady-state levels of IFI16 mRNA and protein prompted us to test
whether increased levels of IFI16 protein in human diploid
fibroblasts could regulate the hTERT expression. Because expres-
sion of hTERT gene in normal HDFs is up-regulated transiently in
the S-phase of cell cycle [28], we chose to treat young WI-38 HDFs
with aphidicolin (a known inhibitor of DNA synthesis that
accumulates cells in the early S phase of the cell cycle; ref. 48), to
examine correlation between IFI16 and hTERT expression.
Treatment of HDFs with aphidicolin at a concentration (5 mg/
ml), which has been used previously [28], for 24 h did not result in
any measurable toxicity. Notably, the treatment of cells with
aphidicolin resulted in significant decreases in the steady-state levels
of IFI16 mRNA (Fig. 1A) and protein (Fig. 1C). Interestingly, using
our optimized conditions to specifically detect low levels of hTERT
mRNA and protein, we found that decreases in the steady-state
levels of IFI16 mRNA and protein were inversely correlated with
thehTERTmRNA(Fig.1B)andprotein(Fig.1C)levels. Consistent
with these observations, we also noted moderate increases in the
activity of telomerase after the treatment of cells (Fig. 1D; compare
the intensity of ladder in lane 3 with lane 6).
Inhibition of histone deacetylase (HDAC) activity in certain cells
inhibits interferon signaling and expression of IFN-inducible genes
[49]. Therefore, we tested whether treatment of WI-38 fibroblasts
with an inhibitor of HDAC (CGK1026), which was reported [29]
to activate transcription of hTERT gene by inhibiting the activity
of the Rb-E2F transcriptional repressor complex, has any effect on
IFI16 and hTERT expression. Treatment of WI-38 cells with
CGK1026 at a concentration (10 mM), which has been used
previously [49], for 24 h did not result in any detectable
morphological changes and resulted in significant decreases in
the steady-state basal levels of IFI16 mRNA (Fig. 2A). Interest-
ingly, the decreases in IFI16 mRNA levels were associated with
increases in hTERT mRNA levels as determined using the
optimized conditions for semi-quantitative RT-PCR (Fig. 2A) and
quantitative real-time PCR (Fig. 2B) to detect low basal levels of
hTERT mRNA. Furthermore, this inverse correlation between
IFI16 and hTERT mRNA levels was also seen at the protein levels
(Fig. 2C and 2D). Notably, basal low levels of hTERT mRNA
were not detectable in unsynchronized cultures of WI-38 cells
(Fig. 2A, compare lane 2 with 1). However, basal levels of hTERT
protein were detectable in unsynchronized cultures of WI-38 cells
(Fig. 2D, compare lane 2 with 1). This could be due to a relatively
short half-life (,2 h) of the hTERT mRNA [50] as compared to
the protein [51]. Taken together, our above observations clearly
demonstrated that the expression of IFI16 protein is inversely
correlated with the hTERT expression in aphidicolin or
CGK1026 treated WI-38 HDFs.
Increased Levels of IFI16 Protein in HeLa Cells Are
Associated with Reduced Levels of c-Myc and hTERT
Forced overexpression of IFI16 protein in Saos2 (a human
osteosarcoma cell line) cells down-regulated the expression of c-
MYC gene [22]. Furthermore, IFI16 protein can bind to the
promoter of the c-MYC gene [23]. Because the promoter region of
the hTERT gene contains c-Myc-responsive elements (E-boxes)
and the transcription of hTERT gene is activated by c-Myc [39–
41], we explored whether increased levels of IFI16 protein in cells
could negatively regulate the expression of hTERT gene through
inhibition of c-Myc-stimulated transcription. Because expression of
c-Myc, hTERT, and IFI16 is readily detectable in HeLa cells and
IFN-treatment of HeLa cells results in down-regulation of c-Myc
[52], we chose these cells to investigate the molecular mechanisms
by which IFN-inducible IFI16 protein may regulate the hTERT
expression. As shown in Fig. 3A, overexpression of IFI16 protein
in HeLa cells significantly decreased the steady-state levels of c-
Myc protein. This observation prompted us to test whether
increased levels of IFI16 protein inhibit c-Myc-stimulated
transcription. As shown in Fig. 3B, transfection of a plasmid
encoding c-Myc protein in HeLa cells stimulated the activity of a
reporter (pMyc-TA-luc) (compare column 2 with 1), expression of
which is driven by the c-Myc-responsive elements. Transfection of
a plasmid encoding IFI16 protein resulted in moderate decreases
in the activity of the Myc-luc-reporter (compare column 3 with 1).
Interestingly, transfection of cells with c-Myc encoding plasmid
along with increasing amounts of the plasmid encoding the IFI16
IFI16 Down-Regulates hTERT
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column 5 or 6 with column 4). Moreover, consistent with our
above observations (Fig. 1) that expression of IFI16 protein is
inversely correlated with hTERT expression, knockdown of IFI16
expression in HeLa cells resulted in increases in hTERT protein
levels (Fig. 3C). These observations indicated that increased levels
of IFI16 protein in HeLa cells down-regulate the hTERT
expression, in part, through down-regulation of the c-Myc
expression and inhibiting c-Myc-stimulated transcription of the
target genes.
Increased Levels of IFI16 Protein in WI-38 Cells Are
Associated with Reduced Levels of hTERT and
Telomerase Activity
Our above observations that increased levels of IFI16 protein in
HeLa cells reduced c-Myc protein levels (Fig. 3A) and inhibited
the c-Myc-stimulated transcription (Fig. 3B), prompted us to
determine whether IFI16 protein also regulates the expression of c-
Myc and its transcriptional target hTERT gene in HDFs. Because
c-Myc protein levels were relatively low in WI-38 HDFs [40], we
chose to knockdown the expression of IFI16 in young WI-38
HDFs. As shown in Fig. 4A, knockdown of IFI16 expression in
WI-38 cells resulted in increases in c-Myc protein levels.
Additionally, over-expression of IFI16 protein in WI-38 cells
resulted in reduced levels of hTERT protein (Fig. 4B). Similarly,
increased levels of IFI16 protein in transfected WI-38 cells (Fig. 4C)
also resulted in measurable reduction in the activity of telomerase
(Figs. 4D and E; compare lane 7 with either lane 5 or 3).
Moreover, consistent with these observations, we also noted that
IFN-a treatment of WI-38 cells for 24 h resulted in reduced
(,50%) steady-state levels of hTERT mRNA as determined by
quantitative real-time PCR (data not shown). Together, these
observations indicated that increased levels of IFI16 protein in
normal HDFs are associated with reduced steady-state levels of
hTERT mRNA and protein and reduced telomerase activity.
The IFI16 Protein Inhibits c-Myc-induced Transcription of
the hTERT Gene
c-Myc is known to activate transcription of the hTERT gene
through cis-elements in the promoter region of the gene [39,40].
Therefore, our above observations that increased levels of the
IFI16 protein in cells are associated with reduced expression levels
of c-Myc and hTERT mRNA and proteins prompted us to test
whether IFI16 protein inhibits c-Myc-stimulated transcription of
the hTERT gene. For this purpose, we transfected young WI-38
cells with a reporter (hTERT-luc) in which transcription of the
reporter was driven by the 59-regulatory region (,2 Kb) of the
human hTERT gene [45]. As shown in Fig. 5, transfection of cells
Figure 1. Reduced expression levels of IFI16 protein in aphidicolin-treated human normal diploid fibroblasts are associated with
increased expression levels of the hTERT and telomerase activity. (A and B) Total RNA isolated from untreated (control) or aphidicolin (5 mg/
ml for 24 h) treated young WI-38 fibroblasts was subjected cDNA synthesis followed by quantitative real-time PCR using the TaqMan assay for the
IFI16 gene (A) or hTERT gene (B). Results are mean values of triplicate experiments and the error bars represent standard deviation (
*p,0.05). (C) Total
protein extracts prepared from untreated (lane 1) or aphidicolin (5 mg/ml for 24 h) treated (lane 2) young WI-38 fibroblasts were subjected
immunoblotting using antibodies specific to the indicated proteins. (D) Extracts containing the indicated amounts (mg) of proteins from control
(lanes 2–4) or aphidicolin-treated (lanes 5–7) young WI-38 cells were subjected to TRAPeze assays without any treatment (lanes 2, 3, 5, and 6) or after
heat treatment (lanes 4 and 7) to detect the telomerase activity. As controls, extracts from HeLa cells (lane 8) or buffer alone (lane 9) were also
included in the assay. The reaction products were subjected to native polyacrylamide gel electrophoresis along with DNA fragments of increasing
length as size markers (DNA-ladder).
doi:10.1371/journal.pone.0008569.g001
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,2.5–3-fold (compare column 2 with 1). Consistent with low c-
Myc levels in WI-38 cells, transfection of IFI16 encoding plasmid
in cells did not result in measurable decreases in the activity of the
reporter. However, transfection of IFI16 encoding plasmid along
with c-Myc encoding plasmid measurably reduced the activity of
the reporter to the basal level (compare column 5 with column 2 or
4). Moreover, we noted that increased expression of c-Myc in WI-
38 cells (in transient transfection assays) resulted in increases in
hTERT protein levels (data not shown). Together, our observa-
tions provided support for the idea that increased levels of IFI16
protein in human normal cells inhibit hTERT expression, in part,
by inhibiting c-Myc-stimulated transcription of the hTERT gene.
Discussion
Certain somatic cells are known to express low, but detectable,
levels of hTERT [27–30] and the levels of hTERT are reported to
increase transiently in the S-phase of cell cycle [28,30]. Therefore,
to detect basal low levels of hTERT protein in nuclear extracts
prepared from unsynchronized cultures of HDFs, we used our
optimized immunoblotting conditions to detect higher molecular
weight proteins [47]. Using a mouse monoclonal antibody 2C4,
which has been shown to be specific to the human hTERT protein
[28,53] or a specific rabbit polyclonal antibody [54], we could
detect the basal low levels of hTERT protein in WI-38 (Fig. 1C)
and other young HDFs, such as BJ and IMR-90 (data not shown).
Moreover, treatment of cells with aphidicolin increased levels of
hTERT mRNA and protein.
Interferon treatment of certain cell types inhibits cell prolifer-
ation through inhibition of the progression of cells through the S-
phase of the cell cycle [55] and increased levels of IFN-inducible
IFI16 protein in HDFs are associated with cellular senescence-
associated cell growth arrest [12], Therefore, after detecting the
basal levels of hTERT protein in human normal HDFs (WI-38,
BJ, and IMR-90), we explored whether IFI16 protein could
negatively regulate the expression of hTERT.
Stable overexpression of IFI16 protein in Saos-2 cells resulted in
inhibition of cell proliferation and accumulation of senescence-
associated b-gal positive cells (a marker of cellular senescence) in
cultures [22]. Interestingly, the accumulation of senescent cells
was accompanied by up-regulation of p21
CIP1 expression and
down-regulation of c-Myc expression [22]. Consistent with these
Figure 2. Reduced expression levels of IFI16 protein in human
normal diploid fibroblasts after treatment with histone
deacetylase inhibitor are associated with increased expression
of hTERT and increased telomerase activity. (A) Total RNA
isolated from untreated (control, lane 1) or CGK1026 (10 mM for 24 h,
lane 2) treated young WI-38 fibroblasts was subjected cDNA synthesis
followed by semi-quantitative PCR using a pair of primer specific to the
IFI16, hTERT, or actin. As a positive control, we used RNA from human
HT1080, a human fibrosarcoma cell line. (B) Total RNA isolated from
untreated (control) or CGK1026 (10 mM for 24 h; treated) treated young
WI-38 fibroblasts was subjected cDNA synthesis, followed by quanti-
tative real-time PCR using the TaqMan assay for the hTERT gene. Results
are mean values of triplicate experiments and error bars represent
standard deviation (
**p,0.005). (C and D) Total protein extracts
prepared from untreated (lane 1) or CGK1026 (10 mM for 24 h; treated)
treated young WI-38 fibroblasts were subjected to immunoblotting
using antibodies specific to the indicated proteins.
doi:10.1371/journal.pone.0008569.g002
Figure 3. IFI16 inhibits c-Myc-stimulated transcription and hTERT expression in HeLa cells. (A) Total protein extracts prepared from HeLa
cells infected with control retrovirus (lane 1) or a virus encoding IFI16 protein (lane 2) were subjected to immunoblotting using antibodies specifict o
the indicated proteins. (B) Sub-confluent cultures of HeLa cells were transfected with pMyc-TA-luc reporter plasmid (1.0 mg) along with a second pRL-
TK reporter plasmid (0.2 mg) and an empty plasmid (pCMV; column 1), a plasmid encoding c-Myc (column 2 and 4), a plasmid encoding IFI16 (column
3), or both plasmids encoding c-Myc and increasing amounts of the plasmid encoding IFI16 protein (column 5 and 6). After 44–48 h of transfections,
cells were lysed and the lysates were analyzed for dual luciferase activity. Normalized relative luciferase activity in control cells is indicated as 1.0. (C)
Total protein extracts prepared from HeLa cells infected with control retrovirus (lane 1) or a virus encoding antisense to IFI16 mRNA (lanes 2) were
subjected to immunoblotting using antibodies specific to the indicated proteins.
doi:10.1371/journal.pone.0008569.g003
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HeLa cells resulted in decreases in c-Myc protein levels (Fig. 3A)
whereas knockdown of IFI16 expression in WI-38 cells resulted in
increases in c-Myc protein levels (Fig. 4A). Notably, our
observation that knockdown of IFI16 expression in WI-38 cells
increased levels of c-Myc is consistent with our previous
observations [12] that the knockdown of IFI16 expression
increased the proliferation potential of WI-38 cells. Furthermore,
overexpression of IFI16 protein in PC-3 human prostate cancer
cell line resulted in senescence-like phenotype and reduced
telomere length [13,14]. Together, these observations support
the idea that the reduced levels of IFI16 protein in cells contribute
to increased proliferation potential through up-regulation of c-
Myc and hTERT levels and increased levels of IFI16 protein in
cells potentiate cellular senescence-associated cell growth arrest by
down-regulating the expression of c-Myc. Because the c-Myc
stimulates the transcription of hTERT gene [39–41], our
observations that increased levels of IFI16 protein in cells decrease
steady-state levels of c-Myc and inhibit c-Myc-stimulated tran-
scription of the hTERT-luc-reporter support the idea that the
IFI16 protein inhibits the transcription of hTERT gene by
negatively regulating c-Myc-mediated transcription.
Presently, it remains unknown how increased levels of IFI16
protein negatively regulate the expression of c-Myc. Because
Figure 4. Increased levels of IFI16 protein in WI-38 cells reduce hTERT levels and inhibit telomerase activity. (A) Total protein extracts prepared
from WI-38cells transfected with control siRNA (lane 1) or IFI16siRNA RNA (lane 2) were subjectedto immunoblotting using antibodies specific to the indicated
proteins. (B) Total protein extracts prepared from WI-38 cells, either transfected with control (pCMV) vector (lane 1) or pCMV-IFI16 plasmid (lane 2), were
subjectedto immunoblottingusingantibodies specific to the indicated proteins. (C)Totalproteinextractspreparedfrom WI-38 cells treated with lipofectamine
(mock, lane 1), transfected with control (pCMV) vector (lane 2) or pCMV-IFI16 plasmid (lane 3) were subjected to immunoblotting using antibodies specific to
the indicated proteins. (D) Extracts containing the indicated amounts (mg) of proteins from mock transfected (lanes 2 and 3)CMV transfected (lanes 4 and 5), or
pCMV-IFI16 transfected (lanes 6 and 7) young WI-38 cells were subjected to TRAPeze assays to detect the telomerase activity. As controls, extracts from HeLa
cells (lane 8) or buffer alone (lane 9) were also included in the assay. The reaction products were subjected to native polyacrylamide gel electrophoresis along
with DNA fragmentsof increasing lengthsassize markers (DNA-ladder, lanes 1 and 10). (E)Quantitation(usingthe Bio-Radimager)of the intensitiesof the DNA
fragments on the gel (in lanes 4, 5, 6, and 7) that were generated during the TRAPeze assays, which is shown in the panel (D).
doi:10.1371/journal.pone.0008569.g004
Figure 5. The IFI16 protein inhibits c-Myc-induced transcription
of the hTERT gene. Sub-confluent cultures of young WI-38 cells were
transfected with hTERT-luc reporter plasmid (1.8 mg) along with a second
reporter pRL-TK (0.2 mg) plasmid and an empty vector (pCMV), c-Myc
encoding plasmid, or IFI16 encoding plasmid as described in methods.
40–44 haftertransfections,firefly luciferaseandRenillaluciferaseactivities
were assayed using dual-luciferase reporter assay kit. Relative luciferase
activity was expressed as the ratio of the firefly luciferase and Renilla
luciferase activity. The numbers indicate fold change in the activity of the
firefly luciferase.
doi:10.1371/journal.pone.0008569.g005
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the promoter region [56], it is tempting to speculate that increased
levels of the IFI16 protein in cells inhibit the transcription of c-
MYC gene by potentiating the pocket protein-E2F-mediated
transcriptional repression (Fig. 6). Further work will be needed
to test this interesting possibility.
Several studies have suggested that telomere dysfunction and
chromosomal aberrations are associated with the aging phenotype
associated with Werner syndrome (WS), a rare human premature
aging disease that is caused by mutations in the gene encoding the
RecQ helicase WRN [57,58]. Moreover, studies have indicated
that telomere elongation by telomerase can significantly reduce the
appearance of new chromosomal aberrations in cells lacking the
WRN [57,58]. Because basal and IFN-induced expression of the
IFI16 varies among individuals [14], our observations that IFI16
negatively regulates the expression of hTERT gene raise the
possibility that increased expression of IFI16 in some individuals,
who may have genetic predisposition to have increased serum
levels of type I IFNs [59], may contribute to premature aging
phenotype. Therefore, further studies are needed to test this
possibility.
p53 deficiency is known to rescue the adverse effects of telomere
loss and cooperate with telomere dysfunction to accelerate
carcinogenesis [60]. Therefore, our previous observations that
the p53 transcriptionally activates expression of the IFI16 gene in
old (versus young) HDFs [61] and our current observations that
increased levels of IFI16 protein negatively regulate the expression
of hTERT raise the possibility that the loss of IFI16 expression in
human cells (or loss of IFI16 function) by cooperating with
telomere dysfunction contributes to carcinogenesis (Fig. 6).
Disruption of telomerase activity in human normal cells slows
cell proliferation, restricts cell lifespan, and changes the mainte-
nance of the 39 single-stranded telomeric overhang without
changing the rate of overall telomere shortening [25,26,62].
Moreover, telomere dysfunction increases mutation rate and
genomic instability [25]. Therefore, it is likely that alterations
(increases or decreases) in the expression of IFI16 protein in
certain individuals contribute to increased susceptibility to
premature aging and aging-dependent cancers.
Previous studies [28,30] and our observations described here
demonstrate that levels of hTERT protein are transiently
increased during the S-phase of cell cycle in human normal
fibroblasts. Although, the role of telomerase activity in cell cycle
progression remains unclear, it is known that hTERT functions
independent of the telomerase activity [63]. Therefore, further
work will be needed to elucidate the role of hTERT in the S-phase
progression.
Inhibitors of HDAC activity, such as TSA and sodium butyrate,
are known to inhibit the expression of IFN-inducible genes [49].
Therefore, our observations that treatment of HDFs with
CGK1026 resulted in down-regulation of IFI16 expression is
consistent with a role for HDAC activity in the regulation of IFI16
expression. Because studies have revealed that dynamic assembly
of E2F-pocket protein-HDAC complex plays a central role in the
regulation of hTERT expression under normal cycling conditions
[29], our observation that treatment of HDFs with CGK1026
resulted in up-regulation of hTERT expression, raises the
possibility that increased levels of IFI16 protein in HDFs
contribute to transcriptional repression of the hTERT gene by
the E2F-pocket protein-HDAC repressor complex. Indeed, the
IFI16 protein sequence contains two LxCxE-like motifs to bind
pRb pocket and it binds to the pRb protein in vitro in GST-pull
down assays [13]. The IFI16 protein also binds to E2F1 [13].
Binding of IFI16 protein to both pRb and E2F1 is associated with
inhibition of the E2F1-mediated transcription of growth-promot-
ing genes whose activity is needed for transit through S-phase of
cell cycle [64]. Additionally, over-expression of IFI16 protein in
medullary thyroid carcinoma cells significantly down-regulated the
expression of the E2F1, a transcriptional repression target of the
pRb-E2F repressor complex [65]. Therefore, our observations that
treatment of HDFs with CGK1026, which down-regulated the
expression of IFI16, make it likely that reduced levels of IFI16
protein in cells potentiate the transcription of the E2F1 target
genes, such as hTERT. Consistent with this idea, we noted that
expression of cyclin E and E2F1, well known transcriptional
targets of the E2F1 [64], was up-regulated in the CGK1026
treated HDFs (data not shown).
Studies have provided evidence that human epithelial cells and
fibroblasts can be immortalized and transformed by over-
expression of hTERT, SV40 large T antigen, and activated
H-Ras oncogene [66]. Notably, we have reported [12] that
immortalization of human fibroblasts with hTERT or SV40 large
T antigen down-regulated the expression of the IFI16 gene and
Figure 6. Increased levels of IFI16 protein in human cells
inhibit c-Myc-induced expression of the hTERT gene.
doi:10.1371/journal.pone.0008569.g006
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resulted in cellular senescence, was associated with up-regulation
of IFI16 expression (data not shown). These observations further
provide support for the idea that the genetic and/or epigenetic
alterations in the human genome that result in defects in cell
signaling pathways and immortalization of cells negatively regulate
the expression of the IFI16 gene. Additionally, our observations
also raise the possibility that defects in signaling pathways that
result in increased expression of the IFI16 gene in certain
individuals contributes to premature ageing and ageing-dependent
diseases.
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